Advisors Asset Management, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,752,179
+12.5%
22,704
+6.2%
0.06%
+18.0%
Q2 2023$2,447,178
+1.7%
21,369
+22.4%
0.05%
+2.0%
Q1 2023$2,406,374
+10.6%
17,459
+4.0%
0.05%
+8.9%
Q4 2022$2,174,871
+17.7%
16,784
+0.4%
0.04%
+15.4%
Q3 2022$1,848,000
+129.9%
16,719
+55.9%
0.04%
+160.0%
Q2 2022$804,000
-52.1%
10,721
-50.1%
0.02%
-42.3%
Q1 2022$1,678,000
-21.6%
21,485
-9.7%
0.03%
-16.1%
Q4 2021$2,141,000
-1.7%
23,780
+1.0%
0.03%
-6.1%
Q3 2021$2,178,000
+18.0%
23,551
-0.8%
0.03%
+22.2%
Q2 2021$1,846,000
+21.1%
23,742
+16.1%
0.03%
+12.5%
Q1 2021$1,524,000
-34.6%
20,446
+49.5%
0.02%
-38.5%
Q4 2020$2,331,000
+94.2%
13,675
+60.1%
0.04%
+77.3%
Q3 2020$1,200,000
+53.6%
8,542
+75.4%
0.02%
+46.7%
Q2 2020$781,000
+474.3%
4,870
+250.6%
0.02%
+400.0%
Q1 2020$136,000
-44.9%
1,389
-27.5%
0.00%
-25.0%
Q4 2019$247,000
-15.4%
1,915
-50.6%
0.00%
-20.0%
Q3 2019$292,000
-49.7%
3,875
+1.3%
0.01%
-50.0%
Q2 2019$581,000
+28.0%
3,825
+0.4%
0.01%
+25.0%
Q1 2019$454,000
+19.8%
3,811
+9.7%
0.01%0.0%
Q4 2018$379,000
-21.9%
3,473
+15.7%
0.01%0.0%
Q3 2018$485,0003,0030.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders